Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We will give an anticoagulant against portal vein thrombosis, and watch for the results.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Anticoagulant in cirrhosis with HCC | Experimental | HCC patient on anticogulant like Enoxaparin (clexan), warfarrin(marivan), or DOAC(apixaban) |
|
| Anticoagulant in Cirrhosis without HCC | Experimental | Benign thrombus in cirrhotic patient on anticoagulant like Enoxaparin (clexan), warfarrin(marivan), or DOAC(apixaban) |
|
| No anticoagualnt in Cirrhosis with or without HCC | No Intervention | cirrhotic patients with thrombosis with or without HCC not on anticoagulant |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Enoxaparin, warfarrin, or apixaban | Drug | Enoxaparin, warfarrin, or apixaban |
|
| Measure | Description | Time Frame |
|---|---|---|
| Portal vein thrombosis | determine if thrombus resolved or not on anticcoagulant by triphasic CT | 6 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dalia Elsayed Ganady, MBBS | Contact | +201095529264 | dalia.tawfik97@gmail.com | |
| Hatem Elalfy, PhD | Contact | +201224790518 | elalfy2004@mans.edu.eg |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mansoura University Hospitals | Recruiting | Al Mansurah | Dakahlia Governorate | 35511 | Egypt |
when this clinical trial will be finished and have the results
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005355 | Fibrosis |
| D006528 | Carcinoma, Hepatocellular |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D000230 | Adenocarcinoma |
| D002277 | Carcinoma |
Not provided
Not provided
| ID | Term |
|---|---|
| D017984 | Enoxaparin |
| C522181 | apixaban |
| ID | Term |
|---|---|
| D006495 | Heparin, Low-Molecular-Weight |
| D006493 | Heparin |
| D006025 | Glycosaminoglycans |
| D011134 | Polysaccharides |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D008113 | Liver Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D004066 | Digestive System Diseases |
| D008107 | Liver Diseases |
| D002241 |
| Carbohydrates |